The global pharmaceutical filtration market is evaluated at US$17.321 billion for the year 2019, growing at a CAGR of 11.67% reaching the market size of US$37.506 billion by the year 2026.
Pharmaceutical filtration is the process in which solid particulate matter is separated from fluids and gases with the help of a porous medium. This process is utilized in many processes such as solvent and bulk filtration, water-based, and air filtration. Growing demand for protein-based drugs because of the rising prevalence of inflammatory, infectious and cardiovascular diseases across the globe is expected to drive the pharmaceutical filtration market growth during the forecast period. Moreover, increasing emphasis on biologics for the development of treatment of various diseases is a major factor contributing to the overall market growth.
Global Pharmaceutical Filtration Market Drivers
One of the prime reasons which is supporting the growth of the pharmaceutical filtration market is the rising prevalence of chronic diseases such as diabetes, asthma, cancer, auto-immune disease, etc. Due to the rising cases of chronic disease, there is an increased demand for advanced therapeutic drugs, globally. According to the world health organization, cancer is one of the major causes of death worldwide accounting for nearly 10 million deaths in 2020. The growing use of tobacco, high body mass index, alcohol use, low fruit and vegetable intake, and lack of physical activity is expected to increase the cases of cancer in the coming years which will create a huge demand for advanced therapeutic drugs which in turn is anticipated to drive the overall market growth during the forecast period.
The increase in the production of vaccines for providing immunization against Covid-19, Dengue, Malaria, and Chikungunya across the globe are driving the growth of the global pharmaceutical filtration market. Moreover, the rising population has increased the demand for generic drugs in countries like India, China, and the US. For instance, Yangtze River Pharmaceutical Group in China has announced the submission of its first marketing application for eslicarbazepine acetate, a class 3 generic medication used to treat epileptic patients. Many countries are working in collaboration with each other for the development of generic pharmaceuticals and medical technology for the treatment of Covid-19 patients, as well as vaccine development. These developments in the market are expected to propel market growth in the future.
Another prime factor that is attributed to the growth of the pharmaceutical filtration market is the increasing investment in the research and development of biologics. The growing adoption of innovative treatment therapies such as monoclonal antibodies, R-DNA technology, therapeutic proteins, and vaccines has increased the number of biotechnology and pharmaceutical companies that utilize filtration techniques including membranes, capsules, cartridges, and others. Additionally, many companies are investing heavily in their research and development plants or manufacturing facilities. Goldman Sachs has announced the investment of $150 million in Biocon biologics which will help the company to invest in their research and development facility and high-quality manufacturing.
Global Pharmaceutical Filtration Market Restraint
Manufacturing facilities of filtration equipment require high capital investments from biopharmaceutical companies. All the equipment and machinery used in production facilities are very expensive. Additionally, the process requires technical knowledge, manufacturing expertise and personnel training which increases the cost of manufacturing. Using and maintaining filtration equipment is quite challenging for companies due to its high cost which is expected to hinder the overall market growth in the future. Strict government regulations can also act as an obstacle for the players operating in the pharmaceutical filtration market, all the pharma companies face various challenges in obtaining FDA approval for any new and innovative products. The use of pharmaceutical filters is validated by FDA Quality by Design (QbD) principles, in Canada, Health Canada regulates the use of pharmaceutical filters with the help of GMP guidelines.
During the projected period, the Asia Pacific and North America are expected to hold a significant proportion of the global pharmaceutical filtration market
Geographically, the global pharmaceutical filtration market is classified into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is expected to dominate the pharmaceutical filtration market during the forecast period. Factors such as the growing biopharma industry and the advancement in manufacturing facilities are expected to contribute to the growth of the market across the region. The Asia Pacific is projected to be the fastest-growing market due to the presence of a large number of patients with chronic ailments and the rising production of vaccines in countries like China and India are further contributing to the growth of the global pharmaceutical filtration market.
Covid-19 Pandemic has a positive impact on the overall market growth. During the Pandemic scientists and researchers were trying their best to manufacture vaccines that can provide immunity against the virus. After the successful development of the vaccine, its mass production takes place which has increased the demand for filters across the pharmaceutical industry which has significantly contributed to the overall market growth.
|Market size value in 2019||US$17.321 billion|
|Market size value in 2026||US$37.506 billion|
|Growth Rate||CAGR of 11.67% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Filtration Type, Technology, Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||3M Company, Danaher Corporation, GE Healthcare, GEA Group, Graver Technologies, Merck Millipore, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Thermo Fisher Scientific|
|Customization scope||Free report customization with purchase|
Key Market Segments
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the pharmaceutical filtration market?
A1. The global pharmaceutical filtration market is projected to grow at a CAGR of 11.67% during the forecast period.
Q2. How is the global pharmaceutical filtration market segmented?
A2. The pharmaceutical filtration market has been segmented based on filtration type, technology, application, and geography.
Q3. What will be the pharmaceutical filtration market size by 2026?
A3. The pharmaceutical filtration market is projected to reach a market size of US$37.506 billion in 2026.
Q4. What is the size of the global pharmaceutical filtration market?
A4. Pharmaceutical Filtration Market was valued at US$17.321 billion in 2019.
Q5. What factors are anticipated to drive the pharmaceutical filtration market growth?
A5. Growing demand for protein-based drugs because of the rising prevalence of inflammatory, infectious and cardiovascular diseases across the globe is expected to drive the pharmaceutical filtration market growth.
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis
5. PHARMACEUTICAL FILTRATION MARKET, BY FILTRATION TYPE
6. PHARMACEUTICAL FILTRATION MARKET, BY TECHNOLOGY
6.2. Cross Filtration
7. PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION
7.2. Water Separation
7.3. Raw Material Filtration
7.4. Product Filtration
8. PHARMACEUTICAL FILTRATION MARKET, BY GEOGRAPHY
8.2. North America
8.2.1. United States
8.3. South America
8.4.3. United Kingdom
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. South Africa
8.6. Asia Pacific
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrative
9.3. Mergers, Acquisition, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.2. Danaher Corporation
10.3. GE Healthcare
10.4. GEA Group
10.5. Graver Technologies
10.6. Merck Millipore
10.7. Parker Hannifin Corporation
10.8. Repligen Corporation
10.9. Sartorius Stedim Biotech
10.10. Thermo Fisher Scientific
Parker Hannifin Corporation
Sartorius Stedim Biotech
Thermo Fisher Scientific
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.